OXT-OXTR pathway active in posterior retina

Article

The posterior retina is a site of oxytocin (OXT) activation of the oxytocin receptor (OXTR), according to a study published online.

The posterior retina is a site of oxytocin (OXT) activation of the oxytocin receptor (OXTR), which may serve as a paracrine signalling pathway contributing to communication between the retinal pigment epithelium and the cone photoreceptor, according to a study published online in Investigative Ophthalmology and Visual Science.

Researchers from the University of Wisconsin (USA), used immunohistochemistry using cell specific markers to localize OXT within a rhesus retina, and reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry to assess the expression of OXTR in both rhesus and human retinas.

To determine the expression of OXTR in cultured human foetal retinal pigment epithelium (hfRPE) cells, the researchers used single-cell RT-PCR and Western blot analyses. To assess transient mobilization of intracellular Ca2+ ([Ca2+]i), the hfRPE cells were loaded with Fura-2-acetoxymethyl ester and studied by ratiometric Ca2+ imaging.

They found that, in the rhesus retina, OXT was expressed in the cone photoreceptor extracellular matrix, and OXTR mRNA and protein were expressed in both the human and rhesus retinal pigment epithelium. In the cultured hfRPE cells, OXTR mRNA and protein expression were observed, and a transient increase of [Ca2+]i was induced by exposure of these cells to 100 nM OXT.

The researchers concluded that OXT and OXTR are present in the posterior retina and OXT causes an increase in hfRPE [Ca2+]i , suggesting that the retina is an active site of the OXT-OXTR signaling pathway.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.